Immune Transcriptome of Cells Infected with Enterovirus Strains Obtained from Cases of Autoimmune Thyroid Disease.
CCL2
IL-18
autoimmunity
cytokine
interferon
pathogenesis
persistent infection
thyroiditis
virus
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
19 Apr 2021
19 Apr 2021
Historique:
received:
05
03
2021
revised:
15
04
2021
accepted:
16
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Hashimoto's thyroiditis and Graves' disease are autoimmune thyroid disorders (AITD) of unknown origin. Enterovirus (EV) infection of thyroid cells has been implicated as a possible initiator of cell damage and of organ-specific autoimmunity. We asked whether persistent infection of human epithelial cells with EV strains obtained from thyroid tissue of AITD patients could be associated with transcriptional changes capable of fostering immunopathology. EV isolates obtained from thyroid tissue of AITD cases were used to infect the AV3 epithelial cell line. AV3 cells incubated with a virus-free medium from thyroid tissue of subjects without evidence of thyroid autoimmunity were used as uninfected controls. Transcripts of immune-related genes were compared in infected vs. uninfected cells. The EV genome and antigens were detected only in the cells exposed to AITD-derived virus isolates, not in control cells. Persistent EV infection, while suppressing transcription of several type I IFN and cytokine determinants, was associated with enhanced transcription of NFKB1/RELA, IFNAR1, JAK1/STAT1, i.e., the determinants that play key immunologic roles. Infection also led to upregulation of the CCL2 chemokine and the IL-18 pro-inflammatory interleukin. As in the case of EV strains obtained from autoimmune diabetes, results show that the EV strains that are present in the thyroid of AITD cases do repress IFN and cytokine pathways. JAK1/STAT1 upregulation supports activation of TLR pathways and aberrant T cell signaling. In the early phases of AITD, our results highlight the potential benefit of interventions aimed at blocking the viral infection and easing the inflammatory response.
Sections du résumé
BACKGROUND
BACKGROUND
Hashimoto's thyroiditis and Graves' disease are autoimmune thyroid disorders (AITD) of unknown origin. Enterovirus (EV) infection of thyroid cells has been implicated as a possible initiator of cell damage and of organ-specific autoimmunity. We asked whether persistent infection of human epithelial cells with EV strains obtained from thyroid tissue of AITD patients could be associated with transcriptional changes capable of fostering immunopathology.
METHODS
METHODS
EV isolates obtained from thyroid tissue of AITD cases were used to infect the AV3 epithelial cell line. AV3 cells incubated with a virus-free medium from thyroid tissue of subjects without evidence of thyroid autoimmunity were used as uninfected controls. Transcripts of immune-related genes were compared in infected vs. uninfected cells.
RESULTS
RESULTS
The EV genome and antigens were detected only in the cells exposed to AITD-derived virus isolates, not in control cells. Persistent EV infection, while suppressing transcription of several type I IFN and cytokine determinants, was associated with enhanced transcription of NFKB1/RELA, IFNAR1, JAK1/STAT1, i.e., the determinants that play key immunologic roles. Infection also led to upregulation of the CCL2 chemokine and the IL-18 pro-inflammatory interleukin.
CONCLUSION
CONCLUSIONS
As in the case of EV strains obtained from autoimmune diabetes, results show that the EV strains that are present in the thyroid of AITD cases do repress IFN and cytokine pathways. JAK1/STAT1 upregulation supports activation of TLR pathways and aberrant T cell signaling. In the early phases of AITD, our results highlight the potential benefit of interventions aimed at blocking the viral infection and easing the inflammatory response.
Identifiants
pubmed: 33921891
pii: microorganisms9040876
doi: 10.3390/microorganisms9040876
pmc: PMC8073039
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Juvenile Diabetes Research Foundation & nPOD-V
ID : JDRF grant 25-2012-770
Organisme : Italian Ministry of Health
ID : grant PE-2013-02357094
Références
Microb Pathog. 2018 Mar;116:279-288
pubmed: 29325864
Sci Rep. 2017 Jul 10;7(1):5013
pubmed: 28694527
Diabetologia. 2016 Nov;59(11):2448-2458
pubmed: 27506584
J Clin Endocrinol Metab. 2017 Feb 1;102(2):689-697
pubmed: 27860532
J Virol. 2003 Nov;77(21):11849-54
pubmed: 14557670
Nat Rev Dis Primers. 2020 Jul 2;6(1):52
pubmed: 32616746
Sci Rep. 2016 Apr 19;6:24757
pubmed: 27091243
Viruses. 2017 Jan 30;9(2):
pubmed: 28146100
PLoS Pathog. 2020 Sep 30;16(9):e1008927
pubmed: 32997711
Trends Endocrinol Metab. 2014 Dec;25(12):611-9
pubmed: 25175301
Nat Rev Endocrinol. 2013 May;9(5):277-87
pubmed: 23529038
Cell Death Differ. 2014 Sep;21(9):1432-41
pubmed: 24769734
Oncotarget. 2019 Mar 5;10(19):1785-1797
pubmed: 30956758
Nat Commun. 2020 Aug 28;11(1):4332
pubmed: 32859902
Viruses. 2020 Jul 11;12(7):
pubmed: 32664501
J Virol. 2021 Jan 13;95(3):
pubmed: 33148796
Science. 1999 Jul 2;285(5424):107-10
pubmed: 10390359
Autoimmun Rev. 2020 Sep;19(9):102614
pubmed: 32663624
Immunol Rev. 2020 Mar;294(1):63-79
pubmed: 31930745
PLoS One. 2013 Nov 01;8(11):e77850
pubmed: 24223733
Diabetologia. 2019 May;62(5):744-753
pubmed: 30675626
Microorganisms. 2020 Sep 15;8(9):
pubmed: 32942706
Chem Rev. 2019 May 8;119(9):5537-5606
pubmed: 30608666
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1763-e1774
pubmed: 33367784
Scand J Immunol. 2020 Dec;92(6):e12984
pubmed: 33037649
J Clin Invest. 2020 Sep 1;130(9):4525-4531
pubmed: 32804154
Sci Adv. 2021 Feb 24;7(9):
pubmed: 33627420
Microorganisms. 2020 Jul 12;8(7):
pubmed: 32664675
Virology. 2020 Sep;548:213-225
pubmed: 32763492
J Med Virol. 2013 Mar;85(3):512-8
pubmed: 23280563
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4180-3
pubmed: 23341590
Microorganisms. 2021 Jan 05;9(1):
pubmed: 33466313
J Clin Virol. 2018 Apr;101:11-17
pubmed: 29414181
Hum Genet. 2020 Jun;139(6-7):919-939
pubmed: 32435828
J Cell Physiol. 2019 Mar;234(3):2204-2216
pubmed: 30246383
Diabetes. 2015 May;64(5):1682-7
pubmed: 25422108
J Clin Microbiol. 2006 Aug;44(8):2698-704
pubmed: 16891480
Front Endocrinol (Lausanne). 2017 Mar 20;8:50
pubmed: 28373861